Evolving Significance and Future Relevance of Anti-Angiogenic Activity of mTOR Inhibitors in Cancer Therapy

mTOR inhibitors have demonstrated remarkable anti-tumor activity in experimental models, mainly by reducing cancer cell growth and tumor angiogenesis. Their use in cancer patients as monotherapy has, however, generated only limited benefits, increasing median overall survival by only a few months. L...

Descripción completa

Detalles Bibliográficos
Autores principales: Faes, Seraina, Santoro, Tania, Demartines, Nicolas, Dormond, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704170/
https://www.ncbi.nlm.nih.gov/pubmed/29104248
http://dx.doi.org/10.3390/cancers9110152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704170/
https://www.ncbi.nlm.nih.gov/pubmed/29104248
http://dx.doi.org/10.3390/cancers9110152

Ejemplares similares